AVIYA expands the offerings and capabilities of CROs, by providing needed clinical development skills in specific therapeutic areas. AVIYA helps CROs to deliver a more complete set of high-value services to their increasingly demanding clients.

Clinical Research Organizations are facing major challenges that are driven by powerful pharmaceutical industry dynamics. Stagnant innovation, anemic pipelines and loss of patent protection, are forcing pharmaceutical firms to rethink the blockbuster model, and to aggressively optimize every aspect of drug development. The biotechnology industry has matured and is providing CROs with increasing amounts of business.

Often, smaller size and earlier stage companies are outsourcing larger portions of their programs to CROs to bolster their internal capabilities and needed expertise. CROs are adapting to these changing conditions by augmenting their capabilities to become development partners rather than simply service providers. CROs are seeking to position themselves early in the process with a set of high value-added services, geared towards targeted drug candidates, by increasing their therapeutic area expertise, and strategic advisory capabilities.